A new study found that it is possible to identify early signs of dementia many years before symptoms appear using a simple blood test.

Neurodegenerative diseases form a tangled biological web with overlapping molecular signatures and symptoms. To decode this ...

Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Drugs developed to reduce levels of a protein found at high levels in Alzheimer’s patients could lead to treatments aimed at curbing the disease before symptoms show up, a new study suggests. A ...

Undertaking a study of proteins found in the complement system, an important part of the immune system, of patients with long COVID, researchers have identified a blood protein ‘signature’ that may ...

A blood biomarker for Alzheimer's disease also indicates damage to the heart and kidneys, complicating early and clinical diagnosis ...

Alzheimer's disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally ...

New data from NAPNAP 2026 emphasizes the need for dual-mechanism reaction protocols to manage atypical food protein-induced enterocolitis syndrome.

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...